Diffusion Pharmaceuticals
DFFN
#10331
Rank
S$11.36 M
Marketcap
S$5.57
Share price
10.28%
Change (1 day)
-37.74%
Change (1 year)

Earnings for Diffusion Pharmaceuticals (DFFN)

Earnings in 2023 (TTM): -S$17.79 Million

According to Diffusion Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -S$19.75 Million, an increase over its 2021 earnings that were of -S$31.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Diffusion Pharmaceuticals from 1999 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$17.79 Million-9.94%
2022 -S$19.75 Million-36.46%
2021 -S$31.08 Million54.72%
2020 -S$20.09 Million38.32%
2019 -S$14.52 Million-39.03%
2018 -S$23.82 Million677.09%
2017 -S$3.07 Million-86.85%
2016 -S$23.3 Million-22.75%
2015 -S$30.17 Million38.74%
2014 -S$21.75 Million598.54%
2013 -S$3.12 Million-57.56%
2012 -S$7.34 Million-62.43%
2011 -S$19.53 Million58.75%
2010 -S$12.3 Million238.41%
2009 -S$3.64 Million189.55%
2008 -S$1.26 Million1576.75%
2007 -S$0.08 Million-35.01%
2006 -S$0.12 Million
1999 -S$9.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.19 Billion 1,031.69%๐Ÿ‡บ๐Ÿ‡ธ USA